跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 112,612 条关于
“University Hospitals Seidman Cancer”
全部
112,612
临床试验
81,881
药物
5,117
机构
5,038
资讯
20,576
6个月前
First Validated Biomarker Transforms Hormone Therapy Decisions in Recurrent Prostate Cancer
去年
Evorpacept Plus Zanidatamab Shows Promise in HER2-Positive and HER2-Low Metastatic Breast Cancer
去年
STX-478 Shows Promise as Mutant-Selective PI3Kα Inhibitor in Solid Tumors
去年
University Hospitals Receives $3.5M Gift to Triple Cancer Clinical Trials Capacity by 2030
去年
Cholesterol Drug Fenofibrate Shows Promise in Treating HPV-Related Cancers
去年
OPTYX Study: Patients and Physicians Prefer Oral Relugolix Over Injectable ADT for Advanced Prostate Cancer
去年
Experts Address Key Challenges in Implementation of Tumor-Agnostic Therapies and Genetic Testing
去年
Zanidatamab and Evorpacept Combination Shows Promise in HER2+ Breast Cancer
2个月前
Oxford-Harrington Rare Disease Centre Appoints First Little Princess Trust Professor of Paediatric Oncology to Accelerate Rare Childhood Cancer Drug Discovery
去年
Exceptional Responders: 14 Pancreatic Cancer Patients Show Remarkable Immunotherapy Outcomes in Multi-Institutional Study
第 1 页，共 2058 页
上一页
下一页
